Postprocedural disorders of eye and adnexa, not elsewhere classified

H7_EYEPOSTOP

eye disease: A non-neoplastic or neoplastic disorder that affects the eye. Representative examples include conjunctivitis, glaucoma, cataract, conjunctival squamous cell carcinoma, uveal melanoma, and retinoblastoma. [NCIt:C26767]

Suggest a new description

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H59
  • Cause of death: ICD-10 H59

2 out of 7 registries used, show all original rules.

92

4. Check minimum number of events

None

92

5. Include endpoints

92

6. Filter based on genotype QC (FinnGen only)

92

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H55-H59
Name in latin
Morbositates oculi et organorum accessoriorum post interventiones non alibi classificatae

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 873 487 378
Only index persons 737 418 319
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.02 0.01
Median age at first event (years)
Whole population 72.77 74.62 70.31
Only index persons 71.58 73.40 69.20

-FinnGen-

Key figures

All Female Male
Number of individuals 92 52 40
Unadjusted period prevalence (%) 0.02 0.02 0.02
Median age at first event (years) 71.47 73.67 68.62

-FinRegistry-

Age distribution of first events

0102030405060708090020406080100120140160180200220240AgeIndividuals

-FinnGen-

Age distribution of first events

04050607080024681012141618202224262830AgeIndividuals

-FinRegistry-

Year distribution of first events

197019751980198519901995200020052010201520202022020406080100120140160YearIndividuals

-FinnGen-

Year distribution of first events

197019751980198519901995200020052010201520202023024681012141618202224YearIndividuals

-FinRegistry-

Cumulative Incidence Function

01020304050607080901000.00.10.20.30.40.50.60.70.80.91.0AgeProbability of first incidence (%)

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
75
Matched controls
748
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H59.9
ICD-10 Finland
Postprocedural disorder of eye and adnexa, unspecified
+∞
32.7
29
*
H59.8
ICD-10 Finland
Other postprocedural disorders of eye and adnexa
+∞
26.6
24
*
H59.0
ICD-10 Finland
Keratopathy (bullous aphakic) following cataract surgery
+∞
21.9
20
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
13.4
21.1
43
68
CKD60
NOMESCO Finland
Anterior vitrectomy
184.5
15.0
15
*
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
+∞
14.0
13
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
6.3
12.5
54
216
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
70.3
11.0
12
*
WX140
NOMESCO Finland
Parabulbar anesthesy
14.4
10.8
18
16
WX100
NOMESCO Finland
Conjunctival surface anesthesia
6.4
9.2
26
57
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
4.7
9.2
48
207
H33.0
ICD-10 Finland
Retinal detachment with retinal break
17.5
8.0
12
8
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
12.8
7.6
13
12
T85.2
ICD-10 Finland
Mechanical complication of intraocular lens
+∞
7.4
7
*
CJE99
NOMESCO Finland
Other extracapsular cataract operation using phakoemulsification technique
+∞
7.4
7
*
S01ED51
ATC
timolol, combinations; ophthalmic
6.4
6.9
18
35
CKD20
NOMESCO Finland
Removal of vitreous body substitute
76.0
6.5
7
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
59
350
2.91
5.69
5.3
5.5
1.23
1.21
mmol/l
1.07
49
319
20
67
3.54
5.21
3.3
4.4
—
—
—
0
0
62
400
2.69
4.73
6.2
6.0
1.23
1.21
mmol/l
1.32
52
324
85
726
3.24
2.85
16.7
16.8
30.55
23.94
mg/l
0.72
76
599
40
251
2.05
2.79
3.6
5.2
—
—
—
0
0
13
49
2.93
2.76
1.0
1.1
—
—
—
0
0
11
38
3.15
2.68
7.5
7.4
—
—
—
0
0
86
747
3.32
2.64
16.3
16.4
—
—
—
0
0
49
341
1.93
2.47
4.8
5.7
24.16
25.94
%
0.46
44
309
50
359
1.86
2.22
5.0
5.2
0.63
0.59
e9/l
0.57
43
308
50
361
1.84
2.16
5.0
5.3
0.04
0.04
e9/l
0.01
43
310
51
373
1.82
2.09
5.1
5.4
0.17
0.19
e9/l
0.47
43
330
25
146
1.98
2.05
3.6
3.6
17.05
113.78
ng/l
1.18
20
123
50
367
1.79
2.00
5.1
5.3
1.75
1.77
e9/l
0.05
44
329
78
667
2.11
1.81
5.0
4.7
1.99
2.01
mu/l
0.05
69
583
35
239
1.75
1.74
1.7
2.3
—
—
—
0
0
69
570
1.84
1.74
4.5
4.3
11.63
13.60
mm/h
0.79
64
506
36
249
1.73
1.71
5.0
4.5
—
—
—
0
0
55
428
1.71
1.69
7.3
9.2
4.72
4.42
e9/l
0.33
48
375
17
94
1.99
1.60
6.0
6.0
-1.77
1.46
mmol/l
—
8
74
45
339
1.64
1.51
2.2
2.0
85.40
94.49
pmol/l
0.56
21
150
32
222
1.68
1.47
3.7
4.6
—
—
—
0
0
84
761
2.19
1.42
20.5
19.6
80.31
81.31
umol/l
0.13
84
761
33
233
1.65
1.41
3.9
3.0
56.83
70.49
mg/l
0.12
18
142
65
549
1.63
1.28
3.6
3.8
15.42
15.09
pmol/l
0.48
56
476
71
613
1.69
1.28
17.9
18.0
38.67
39.77
%
0.35
36
382
8
38
2.21
1.22
2.1
3.3
1.35
1.31
g/l
—
8
33
15
231
0.58
1.10
3.7
3.7
—
—
—
0
0
11
60
1.95
1.08
2.8
2.8
—
—
—
0
0
33
248
1.52
1.05
4.4
4.0
19.45
10.89
mg/mmol
0.22
16
149
32
239
1.52
1.05
3.8
2.9
6.70
7.14
mmol/l
0.25
25
186
78
704
1.71
1.02
5.2
5.2
6.11
6.08
mmol/l
0.08
68
627
10
54
1.96
1.01
4.1
2.6
—
—
—
0
0
0
32
0.00
0.97
0.0
1.5
—
—
—
0
0
44
356
1.45
0.96
3.8
3.9
42.18
47.88
ng/l
0.13
28
265
8
42
1.99
0.91
1.3
1.8
—
—
—
0
0
6
29
2.14
0.91
2.8
4.1
—
—
—
0
0
60
523
1.42
0.82
5.7
5.0
—
—
—
0
0
12
76
1.67
0.76
2.4
3.6
—
—
—
0
0
7
38
1.91
0.75
1.0
1.3
—
—
—
0
0
5
28
1.83
0.67
1.8
1.0
—
—
—
0
0
17
229
0.68
0.67
4.3
4.4
0.00
0.00
estimate
—
8
81
7
44
1.64
0.67
9.6
8.6
20.84
24.88
mmol/l
—
7
38
73
670
1.43
0.66
4.0
4.3
1.31
1.24
mmol/l
0.32
62
595
5
29
1.76
0.65
4.8
1.8
—
—
—
0
0
40
336
1.34
0.64
9.5
10.3
1.48
1.30
inr
—
9
114
8
49
1.69
0.64
3.6
2.5
8.70
9.66
g/l
—
8
39
78
728
1.47
0.60
4.9
5.4
2.59
2.60
mmol/l
0.02
66
644
0
23
0.00
0.59
0.0
1.7
—
—
—
0
0
18
134
1.43
0.59
1.3
1.3
51.50
35.56
iu/ml
—
6
41
75
697
1.41
0.57
4.5
4.8
4.55
4.51
mmol/l
0.14
65
626
13
92
1.48
0.54
1.3
1.5
—
—
—
0
0
10
67
1.55
0.52
3.0
3.5
—
—
—
0
0
23
185
1.32
0.48
1.7
1.7
824.26
1273.57
nmol/l
3.26
18
131
5
32
1.59
0.43
3.0
2.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
2.3
—
87.79
—
0
15
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
19
231
0.78
0.38
4.3
4.2
—
—
—
0
0
5
76
0.64
0.37
1.2
1.3
—
—
—
0
0
26
221
1.25
0.36
1.9
1.5
19.17
22.83
nmol/l
0.60
19
179
73
693
1.26
0.33
4.6
4.9
1.51
1.49
mmol/l
0.15
63
616
26
224
1.22
0.32
3.7
3.1
—
—
—
0
0
12
93
1.33
0.32
1.0
1.4
—
—
—
0
0
27
235
1.21
0.30
3.8
3.2
0.95
0.50
e6/l
0.36
22
178
5
72
0.68
0.27
1.6
1.5
—
—
—
0
0
56
524
1.18
0.27
3.6
4.4
—
—
—
0
0
17
143
1.23
0.25
1.2
1.4
2.94
2.90
g/l
—
10
72
6
80
0.73
0.25
5.5
4.1
—
—
—
0
0
32
290
1.16
0.22
2.0
3.3
2.41
2.34
mmol/l
2.41
22
247
5
42
1.20
0.22
2.6
2.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
434.60
—
0
5
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
9
113
0.77
0.21
1.3
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.9
—
312.61
—
0
12
17
193
0.85
0.18
8.6
6.9
—
—
—
0
0
5
65
0.76
0.17
2.2
1.4
—
—
—
0
0
31
286
1.13
0.16
4.8
4.3
20.28
65.76
e6/l
2.16
25
213
12
102
1.20
0.16
3.4
4.8
1.07
1.04
mmol/l
0.13
12
92
32
344
0.89
0.15
9.6
11.5
0.00
0.01
e9/l
0.52
23
288
71
688
1.14
0.15
7.1
6.8
40.77
41.35
mmol/mol
0.18
62
625
7
86
0.80
0.15
1.4
1.9
—
—
—
0
0
28
299
0.91
0.11
2.2
2.2
—
—
—
0
0
5
48
1.04
0.09
9.2
6.1
22.16
25.00
mmol/l
—
5
48
5
48
1.04
0.09
3.6
4.3
0.00
0.09
e6/l
—
5
48
6
53
1.14
0.09
1.7
2.0
—
—
—
0
0
37
387
0.93
0.09
3.8
4.2
0.00
0.00
estimate
—
8
86
6
58
1.04
0.08
13.0
8.4
—
—
—
0
0
7
63
1.12
0.08
1.4
1.4
—
—
—
0
0
17
183
0.91
0.07
1.5
1.4
—
—
—
0
0
28
266
1.08
0.07
3.8
3.9
—
—
—
0
0
9
87
1.04
0.07
1.1
1.2
—
—
—
0
0
17
161
1.07
0.03
3.1
3.8
—
—
—
0
0
38
390
0.96
0.03
4.8
5.6
0.00
0.00
estimate
—
8
82
15
148
1.02
0.00
3.5
2.9
0.42
0.79
ug/l
—
8
95
36
363
0.99
0.00
4.4
4.2
33.09
34.68
g/l
0.69
31
340
16
155
1.04
0.00
5.0
4.3
—
—
—
0
0
12
119
1.01
0.00
1.3
2.2
—
—
—
0
0
39
394
0.98
0.00
3.7
4.2
0.00
0.00
estimate
—
8
78
5
52
0.96
0.00
13.0
7.8
1.78
1.50
%
—
5
52
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
5
49
1.02
0.00
1.2
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
8
84
0.95
0.00
1.1
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
6
59
1.02
0.00
2.0
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.7
—
7.53
—
0
6
0
5
0.00
0.00
0.0
2.6
—
11.16
—
0
5
5
51
0.98
0.00
13.0
7.8
0.48
0.71
%
—
5
51
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint H7_EYEPOSTOP and mortality.

Females

Parameter HR [95% CI] p-value
H7_EYEPOSTOP 1.239 [0.99, 1.54] 0.057
Birth year 0.994 [0.99, 1.0] 0.174

During the follow-up period (1.1.1998 — 31.12.2019), 153 out of 404 females with H7_EYEPOSTOP died.

Males

Parameter HR [95% CI] p-value
H7_EYEPOSTOP 1.275 [0.95, 1.71] 0.102
Birth year 0.986 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 132 out of 311 males with H7_EYEPOSTOP died.

Mortality risk

Mortality risk for people of age

years, who have H7_EYEPOSTOP.

N-year risk Females Males
1 0.117% 0.248%
5 0.685% 1.393%
10 1.707% 3.671%
15 3.339% 6.617%
20 5.871% 11.493%

Relationships between endpoints

Index endpoint: H7_EYEPOSTOP – Postprocedural disorders of eye and adnexa, not elsewhere classified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data